Results 131 to 140 of about 51,637 (256)

Seropositivity in Myasthenia Gravis as a Predictor of Response to Therapeutic Plasma Exchange

, 2019
Aktham Ismail Alemam, Amal Ismail Abdulrahman   +1 more
openalex   +2 more sources

THE CHALLENGING DIAGNOSIS OF CONCOMITANT INFLAMMATORY MYOPHATY AND MYASTHENIA GRAVIS ASSOCIATED WITH THYMOMA: A CASE REPORT. [PDF]

, 2019
MAÍRA SCHEIBLER, ISABEL CRISTINA FELTES, DANIEL WEISSBLUTH DE TOLEDO, ROGÉRIO SCHOFFEL, CLAITON BRENOL   +4 more
openalex   +1 more source

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.
ABSTRACT Timely diagnosis of type 1 diabetes (T1D), especially in high‐risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases,
Nick Thomas, Bijay Vaidya, Richard David Leslie, Daniel Agardh, Richard Oram, Dana Dabelea, Arunjot Singh, Dimitrios Chantzichristos, Marian Rewers   +8 more
wiley   +1 more source

Overlap Syndrome and Myasthenia Gravis: An Uncommon Association With Unusual Features

, 2019
Gautam Ray
openalex   +1 more source

Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Individuals with type 1 diabetes exhibit significantly increased prevalence of additional autoimmune diseases. Epidemiological, familial and mechanistic evidence indicates frequent polyautoimmunity and shared genetic and environmental drivers. Coexistence complicates clinical management, and autoantibody‐based detection often identifies preclinical ...
George J. Kahaly, Thomas Forst, Monika Kellerer, Stefanie Lanzinger, René D. Rötzer, Matthias Schott, Petra‐Maria Schumm‐Draeger   +6 more
wiley   +1 more source

History of myasthenia gravis revisited

, 2020
Feza Deymeer
openalex   +2 more sources

Multiple Cranial Neuropathies After Lenvatinib–Pembrolizumab Therapy for Metastatic Renal Cell Carcinoma: A Case Report

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Multiple cranial neuropathy is a rare manifestation of immune‐related adverse events. To date, no cases have been reported during immune checkpoint blockade for metastatic renal cell carcinoma. This report describes a case of multiple cranial neuropathy that developed during lenvatinib and pembrolizumab combination therapy.
Hideyuki Minagawa, Tomoyuki Kaneko, Keiichi Hokkoku, Ayano Miyashima, Inoue Hazuki, Ono Tenei, Risako Yagi, Kenjiro Kishitani, Kazuki Takei, Tohru Nakagawa   +9 more
wiley   +1 more source

Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics

Frontiers in Immunology
Xiaoting Lin, Xiaoting Lin, Xiaoting Lin, Xiaoting Lin, Peng Liu, Peng Liu, Peng Liu, Peng Liu, Guoyan Qi, Guoyan Qi, Guoyan Qi, Guoyan Qi   +11 more
doaj   +1 more source

Immunoglobulin for myasthenia gravis. [PDF]

Cochrane Database Syst Rev
Manolopoulos A, Alzuabi M, Elmashala A, Cashwell J, Murad MH, Naddaf E.   +5 more
europepmc   +1 more source

Clinical Characteristics of Patients Initially Suspected of Long COVID: A Case Series From a Specialized Outpatient Clinic

Journal of General and Family Medicine, Volume 27, Issue 1, January 2026.
ABSTRACT Background Sequelae of the acute phase of coronavirus disease 2019 (COVID‐19), termed long COVID, are characterized by a variety of symptoms, including neurological manifestations. Diagnosing long COVID requires excluding alternative conditions that could explain the symptoms.
Masayuki Ohira, Takashi Osada, Hiroaki Kimura, Terunori Sano, Masaki Takao   +4 more
wiley   +1 more source